Lactic Acid Bacteria / Probiotics · Testing Standards and Analytical Methods

Abstract

Lactic Acid Bacteria (LAB) and probiotic health food products continue to expand in the market, encompassing product formats ranging from capsules, tablets, and powders to fermented beverages. However, consumers face a fundamental challenge when making purchasing decisions: bacterial count labeling is inconsistent, testing methodologies vary, and it is difficult to assess data credibility based on product packaging alone. This paper systematically examines core testing dimensions—including viable cell count determination, strain identification, heavy metal testing, microbial contamination control, and product stability assessment—from a methodological perspective. Drawing on Japan's domestic and major international regulatory frameworks, it provides consumers with actionable guidance for interpreting test reports. No efficacy or medical claims are made herein; all discussion is confined to the scope of verifiable analytical methods and labeling transparency.

---

I. Overview of Testing Standards Frameworks

1.1 Japan's Domestic Regulatory Framework

Testing standards for LAB-based health food products in Japan are distributed across multiple regulatory tiers:

• Food Sanitation Act (Shokuhin Eisei-hō): Sets maximum limits for harmful microorganisms, heavy metals, and pesticide residues in food; applicable to all food categories.
• Health Promotion Act (Kenkō Zōshin-hō): Governs nutrition labeling requirements and restricts the scope of functional claims.
• Foods with Function Claims (Kinōsei Hyōji Shokuhin) System (in effect since 2015): Companies may submit functional claims to the Consumer Affairs Agency, but must provide systematic literature reviews or human clinical trial reports. The quality of testing data directly influences the validity of submitted claims.
• JHNFA (Japan Health and Nutrition Food Association) GMP Compliance Certification: This certification requires manufacturing facilities to establish documented testing systems covering incoming raw material inspection, in-process manufacturing controls, and outgoing product release. Facilities holding a certification registration number are subject to periodic audits, and testing records must be fully traceable.

1.2 International Reference Standards

companies exporting products are typically required to comply with both domestic standards and those of the target market; accordingly, some premium-grade products are accompanied by multiple sets of test reports.

---

II. Viable Cell Count Determination: Methodological Analysis of a Core Metric

2.1 Colony-Forming Unit (CFU) Method

The Colony Forming Unit (CFU) is currently the most widely used quantitative indicator for viable cell counts. The standard procedure is as follows:

• 1. Sample preparation: After sampling, samples are immediately diluted under anaerobic or microaerophilic conditions to prevent bacterial count reduction due to oxygen exposure.
• 2. Culture medium selection: MRS (de Man, Rogosa and Sharpe) medium is suitable for most *Lactobacillus* species; M17 medium is used for *Streptococcus* species (e.g., *Streptococcus thermophilus*).
• 3. Incubation conditions: 37°C for 48–72 hours, with strict temperature and humidity control.
• 4. Counting and calculation: Colonies are counted at dilution levels yielding 30–300 colonies per plate, and the original concentration is calculated by applying the corresponding dilution factor.

Methodological limitations: The CFU method counts only culturable viable cells and cannot identify bacteria in a "viable but non-culturable" (VBNC) state. In some freeze-dried powder products, bacterial cells are in a dormant state, and standard CFU enumeration may underestimate the actual number of metabolically active bacteria.

2.2 Flow Cytometry

Flow cytometry, combined with fluorescent dyes (e.g., the LIVE/DEAD BacLight kit), can differentiate bacterial cells on the basis of membrane integrity. It offers high sensitivity and rapid detection speed, making it well suited for high-throughput quality control applications. This method has been adopted by major dairy companies and probiotic ingredient suppliers; however, conversion factors between flow cytometry results and CFU values must be validated internally within each laboratory.

2.3 qPCR (Quantitative Polymerase Chain Reaction)

qPCR amplifies and quantifies specific genomic regions of target strains, enabling detection of total bacterial load including DNA from dead cells. It is often used in conjunction with the CFU method to assess the ratio of dead to viable cells. This technique is of significant value in strain traceability and adulteration detection (see Section III).

2.4 The Importance of the Measurement Time Point

The practical significance of a viable cell count depends on when it was measured. Common industry practices include:

• At time of manufacture: Reflects peak production counts; does not guarantee that this level is maintained throughout the shelf life.
• At end of shelf life / at expiry: A more conservative and consumer-relevant figure, which must be supported by stability data.

Consumers should prioritize products that guarantee viable cell counts at the end of shelf life, and should verify whether stability study data is publicly disclosed.

---

III. Strain Identification and Purity Testing

3.1 Limitations of Phenotypic Identification

Conventional morphological observation and biochemical profiling (e.g., API strip systems) can identify bacteria only to the genus or species level and cannot distinguish between different strains within the same species. Because "strain specificity" is a core principle of probiotic research—meaning that biological characteristics of different strains within the same species may vary significantly—phenotypic methods are insufficient to support high-quality product label claims.

3.2 Molecular Biological Identification Methods

16S rRNA gene sequencing is currently the gold standard for bacterial species and genus identification. By amplifying and sequencing the hypervariable regions (V3–V4) of the 16S rRNA gene and comparing results against GenBank or SILVA databases, species-level identification can be achieved at low cost with fully traceable results.

Whole Genome Sequencing (WGS) enables precise strain-level identification while simultaneously revealing safety-relevant information such as antibiotic resistance genes and virulence factors. The European Food Safety Authority (EFSA) has incorporated WGS data into its requirements for probiotic safety assessments, and leading companies are progressively adopting this standard as well.

PFGE (Pulsed-Field Gel Electrophoresis) and MLST (Multilocus Sequence Typing) can be used for manufacturing environment surveillance to trace contamination sources and verify batch-to-batch consistency.

3.3 Purity Verification for Multi-Strain Products

Multi-strain products (e.g., formulations containing multiple *Lactobacillus* and *Bifidobacterium* species) must verify that the proportion of each strain is consistent with label claims. Metagenomic sequencing can provide an unbiased estimate of mixed microbial populations, but due to its relatively high cost, it is currently used primarily during research and development validation rather than routine batch release testing.

---

IV. Heavy Metal Testing: Standards and Analytical Techniques

4.1 Regulatory Limit Basis

The Food Sanitation Act specifies limits for lead (Pb), arsenic (As), cadmium (Cd), and mercury (Hg) in food. Health food products typically also reference the following standards:

• Pharmacopoeia (JP): Contains explicit heavy metal limits for ingredient-grade materials.
• JECFA (Joint FAO/WHO Expert Committee on Food Additives): Provides internationally applicable Provisional Tolerable Weekly Intake (PTWI) reference values.

4.2 Mainstream Analytical Methods

Sample pretreatment has a significant impact on results. Microwave digestion reduces losses of volatile elements (such as mercury and arsenic) compared to wet acid digestion, and is the recommended approach for high-precision testing.

4.3 Correlation Between Raw Material Origin and Heavy Metal Risk

Primary sources of heavy metals in probiotic products include culture medium raw materials (e.g., yeast extract, glucose), migration from packaging materials, and wear from processing equipment. Selecting suppliers with raw material origin traceability systems, and requiring suppliers to provide Certificates of Analysis (CoA), are upstream measures for controlling heavy metal risk.

---

V. Microbial Contamination Control and Limit Testing

5.1 Pathogen Screening Parameters

In accordance with the Food Sanitation Act and industry self-regulatory standards, LAB products must be tested for at least the following:

• *Salmonella* spp.: Must not be detected in a 25 g/mL sample.
• *Staphylococcus aureus*: Typically required to be \<100 CFU/g.
• Coliform bacteria: Indicator organisms reflecting hygienic status; limits vary by product form.
• Molds and yeasts: Must be strictly controlled in dry dosage forms.
• Total Aerobic Count (TAC): Used to assess overall hygiene status.

5.2 Standardization of Testing Methods

Methods such as ISO 6579 (*Salmonella*), ISO 6888 (*S. aureus*), and ISO 4833 (aerobic count) have been widely adopted. In recent years, real-time PCR and ELISA rapid detection kits (e.g., the bioMérieux VIDAS system) have seen increased use in in-process monitoring due to their ability to deliver results within 24 hours; however, positive samples must still be confirmed by conventional culture methods.

5.3 Cross-Contamination Prevention Systems

Microbiological control in GMP-certified facilities relies not only on finished product testing, but requires the establishment of comprehensive in-process monitoring systems:

• Environmental Monitoring Program (EMP): Regular sampling of production area surfaces and air.
• Personnel hygiene management and classified clean area zoning.
• Cleaning Validation: Demonstrating that cleaning procedures effectively remove residues.

The completeness of the above system documentation is a significant scoring criterion in JHNFA GMP Compliance Certification audits.

---

VI. Product Stability Testing and Shelf-Life Data

6.1 Stability Study Design

Reduction in viable cell counts over time and under varying environmental conditions is an inherent characteristic of LAB products. Stability studies must adhere to the following principles:

• ICH Q1A guidelines (some health food companies adopt this pharmaceutical stability framework as a reference): long-term studies (25°C/60% RH), accelerated studies (40°C/75% RH), and intermediate condition studies.
• Viable cell counts must be determined at each time point (0, 3, 6, 9, 12, 18, and 24 months) and used to plot a decay curve.
• Packaging format (aluminum foil blister pack vs. plastic bottle), desiccant configuration, and nitrogen-flushing protection all significantly affect stability outcomes.

6.2 How to Interpret Stability Data

High-transparency companies will publicly disclose stability data summaries. Consumers should pay attention to:

• 1. Whether viable cell counts at end of shelf life meet the label claim.
• 2. Whether test conditions encompass ambient storage scenarios (summer ambient temperatures in Japan can reach 35°C; confirm that the test temperature range provides adequate coverage).
• 3. Whether an "overage" strategy is employed: i.e., whether a surplus quantity of bacteria is added at the time of manufacture to compensate for decay; this must be disclosed in the labeling or product literature.

---

VII. Key Points for Interpreting Test Reports

A compliant third-party test report should contain the following elements:

Companies that display only internal test reports without disclosing third-party testing results are of questionable data credibility. Reports that aggregate data from multiple lots without providing specific lot numbers similarly lack traceability value.

---

VIII. Actionable Points for Consumers

• 1. Verify the bacterial count time point: Prioritize products that specify a guaranteed viable cell count at the end of shelf life, rather than those that only state bacterial counts "at time of manufacture" (*seizō-ji kinsu*).
• 2. Request third-party test documentation: Ask companies whether they can provide third-party test reports issued by ISO/IEC 17025-accredited laboratories, with particular focus on viable cell counts, heavy metals, and pathogens.
• 3. Confirm strain-level precision on labeling: Product labels should identify bacteria to the strain level (e.g., *Lactobacillus acidophilus* LA-5). Labels that only state the genus (e.g., "lactic acid bacteria") provide no basis for determining specific origin or characteristics.
• 4. Check GMP certification status: The validity of a facility's certification registration number can be verified on the JHNFA official website. Information such as certification registration number 34225 falls within the scope of publicly verifiable records.
• 5. Pay attention to storage conditions: Testing data is generated under specific storage conditions. If a product requires refrigeration but actual distribution temperatures are higher, stability data loses its reference value.
• 6. Distinguish "viability" from "quantity": A high bacterial count does not equate to viability at the target site. Gastric acid resistance and enteric delivery technologies (e.g., enteric coating) must be supported by corresponding in vitro dissolution data; such data does not constitute a claim regarding in vivo effects.
• 7. Verify raw material traceability: Ask companies whether they can provide raw material CoAs (Certificates of Analysis) and supplier audit records. These are the fundamental safeguards for heavy metal risk control.

---

Conclusion

Quality assessment of LAB and probiotic health food products constitutes a multidimensional, multi-methodological analytical system, in which viable cell count determination, strain identification, heavy metal testing, and microbial contamination control each have their corresponding standard methods and interpretive frameworks. Consumers cannot perform laboratory analyses directly, but can make more informed judgments within verifiable dimensions by requesting that companies disclose third-party test reports, verifying GMP certification status, and scrutinizing the precision of label information.

The value of a standard lies in its execution and transparency. A genuinely high-quality product should have testing data that withstands independent third-party reproducibility verification, and its label information should be traceable to corresponding data points in the test reports on a one-to-one basis. This is the core criterion that distinguishes high-transparency brands from ordinary products, and it is the necessary path for the health food industry to continually build consumer trust.

---

*The content of this document covers only verifiable dimensions such as analytical methods, testing standards, and labeling transparency. It does not constitute medical advice, nor does it represent any efficacy claim for any specific product or brand.*